The Phonak Cycling Team will be armed with the sme of the most advanced bikes ever built for this years Tour de France. BMC have built them ultra light bikes made from carbon nanotubes that utilise...
http://www.azonano.com/article.aspx?ArticleID=1298 | 11 Jul 2005
Suntech Power Holdings Co., Ltd. (NYSE: STP), the world's largest producer of solar panels, today announced that it is in the process of acquiring 375MW of ingot and wafer slicing capacity in...
http://www.azonano.com/news.aspx?newsID=20626 | 20 Nov 2010
Shimadzu Scientific Instruments (SSI) is the American subsidiary of Shimadzu Corporation, headquartered in Kyoto, Japan. Founded in 1875, Shimadzu is a $2 billion multinational corporation with three...
The SALD-7101 powder and particle size analyzer from Shimadzu is the first in the world to adopt a 375 nm UV semiconductor laser. This provides a great new tool for research and development in...
Researchers would like to develop lithium-ion batteries using titanium dioxide,
an inexpensive material. But titanium dioxide on its own doesn't perform well
enough to replace the expensive,...
http://www.azonano.com/news.aspx?newsID=13769 | 22 Sep 2009
an Indian pharmaceutical company, has launched Albupax, its first nanotechnology
drug. Albupax is the first generic version of the international brand –
http://www.azonano.com/news.aspx?newsID=7738 | 20 Sep 2008
HORIBA Scientific is the world-leading manufacturer of high performance spectroscopic instrumentation for all applications from R&D to routine analysis. Our instruments are used in...
DynaMyc is the user friendly instrument for investigating dynamic events in microscopic samples, such as energy transfer and molecular binding. HORIBA Scientific, leader in fluorescence spectroscopy,...
Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, today announced that the Company has received verbal notice from the U. S. Food and Drug...
http://www.azonano.com/news.aspx?newsID=30550 | 4 Jul 2014
Tekmira Pharmaceuticals Corporation (TSX:TKM), a leader in RNA interference (RNAi) therapeutics, announced today that, together with collaborators at The University of Texas Medical Branch, it has...
http://www.azonano.com/news.aspx?newsID=20028 | 15 Oct 2010